Abaxis, Inc. to Present at Stephens Fall Investment Conference

UNION CITY, Calif., Nov. 9, 2010 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Donald Wood, chief operations officer, will present at the Stephens Fall Investment Conference on Wednesday, November 17, 2010 at 11:30 a.m. ET. The conference will be held at the New York Palace Hotel in New York City.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

Contact:

Clint Severson

Lytham Partners, LLC


Chief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum


ABAXIS, Inc.

602-889-9700


510-675-6500


SOURCE Abaxis, Inc.

MORE ON THIS TOPIC